Apr 2026 Making Sense of Benzodiazepine Results: Clinical and Practical Implications of POCT vs. Definitive Testing
Point of care (POC) immunoassays for benzodiazepines are widely used in outpatient, inpatient, and behavioral...
In Practice: Clinical Insights
Jan 2026 What Did My Patient Actually Take? An Overview of Cannabinoids and Semi-Synthetic Cannabinoids
Cannabinoids are classified into three categories based on origin and method of production: natural, semi-synthetic, and synthetic. Natural cannabinoids, such...
Nov 2025 What Did My Patient Actually Take? An Overview of Kratom Alkaloids in Clinical Practice
Kratom is a psychoactive plant derived from the leaves of the Mitragyna speciosa tree, which is indigenous to Southeast Asia.1...
Oct 2025 Opioid Use Disorder: Evaluating Risk of Return to Use
Supporting patients with opioid use disorder (OUD) requires ongoing vigilance, as the risk of return to use remains a critical...
Aug 2025 2025 Mid-Year Update on Novel Psychoactive Substances (NPS) Trends
The goal of this clinical update is to review the prevalence of NPS detected at Aegis and trends in detection...
Jun 2025 New Additions to the Aegis Behavioral Health Testing Menu
Benztropine & Trihexyphenidyl Pharmacology: Benztropine and trihexyphenidyl are anticholinergic drugs that block muscarinic acetylcholine...
